Preventing and Treating
Thromboembolism in the 21st Century

Supplement 1 to Volume 72, April 2005

Supplement Editor:
AMIR K. JAFFER, MD
Medical Director, IMPACT (Internal Medicine Preoperative
Assessment Consultation and Treatment) Center and
Anticoagulation Clinic, Section of Hospital Medicine
Cleveland Clinic Foundation


Associate Editors:
DANIEL J. BROTMAN, MD, FACP

Director, Hospital Medicine Fellowship
Cleveland Clinic Foundation

ALPESH N. AMIN, MD, MBA
Executive Director, Hospitalist Program
Medical Director, Anticoagulation Clinic
Vice Chair for Clinical Affairs
Department of Medicine
University of California, Irvine

Supplement
April
2005

Supplement 1
to Volume 72

 

This supplement is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

This supplement was developed in print form
as a certified CME activity. To complete the activity for free CME credit, please request a free print copy of the supplement by e-mailing dunaskk@ccf.org.

Guidelines for grant-supported supplements  to the Cleveland Clinic Journal of Medicine

 

 

 

 

 

 

 

 

Education Home | CCF Home | CCJM Home

The Cleveland Clinic Foundation
Cleveland Clinic Journal
of Medicine
9500 Euclid Avenue, NA32
Cleveland, Ohio 44195

216.444.2661, FAX 216.444.9385
  ccjm@ccf.org

 

CONTENTS

Author and Editor Disclosures
 

 

Foreword
 

A pharmacologic overview of current and emerging anticoagulants
Edith A. Nutescu, PharmD; Nancy L. Shapiro, PharmD; Aimee Chevalier, PharmD;
and Alpesh N. Amin, MD, MBA
 

Prevention of venous thromboembolism in medical and surgical patients
Peter J. Kaboli, MD; Adam Brenner, BS; and Andrew S. Dunn, MD

Current and emerging options in the management of venous thromboembolism
Amir K. Jaffer, MD; Daniel J. Brotman, MD; and Franklin Michota, MD
 


Stroke prevention in atrial fibrillation: Current anticoagulation management
and future directions

Benjamin T. Fitzgerald, MBBS; Steven L. Cohn, MD; and Allan L. Klein, MD
 

Heparin-induced thrombocytopenia: Principles for early recognition and management
John R. Bartholomew, MD; Susan M. Begelman, MD; and Amjad Almahameed, MD
 

Anticoagulation in special patient populations: Are special dosing considerations required?
Franklin Michota, MD, and Geno Merli, MD
 

Cost considerations surrounding current and future anticoagulant therapies
Margaret C. Fang, MD, MPH; Tracy Minichiello, MD; and Andrew D. Auerbach, MD, MPH

Copyright © 2005 The Cleveland Clinic Foundation.

The statements and opinions expressed in this supplement to the Cleveland Clinic Journal of Medicine are those of the authors and not necessarily of The Cleveland Clinic Foundation, its Board of Trustees, or AstraZeneca Pharmaceuticals LP. They do not necessarily represent formal practice guidelines in effect at The Cleveland Clinic.

The Cleveland Clinic Journal of Medicine (ISSN 0891-1150) is published 12 times yearly by the Cleveland Clinic Foundation.

Subscription rates: U.S. and possessions: personal $103; institutional $129; single copy/back issue $18. Foreign: $129; single copy/back issue $18. Institutional (multiple-reader rate) applies to libraries, schools, hospitals, and federal, commercial, and private institutions and organizations. Individual subscriptions must be in the names of, billed to, and paid by individuals.

Postmaster address changes: Cleveland Clinic Journal of Medicine, NA32, 9500 Euclid Avenue, Cleveland, OH 44195. Subscription orders, editorial, reprint, and production offices (same address): Phone (216) 444-2661; Fax (216) 444-9385; E-mail, ccjm@ccf.org; World Wide Web address: http://www.ccjm.org

Printed in USA.